Not every reversible airflow limitation is asthma.
Zhao K, Nie H.
Chin Med J Pulm Crit Care Med. 2023 May 2;1(2):125-127. doi: 10.1016/j.pccm.2023.04.002. eCollection 2023 Jun.
Pathological Mechanism and Targeted Drugs of COPD.
Guo P, Li R, Piao TH, Wang CL, Wu XL, Cai HY.
Int J Chron Obstruct Pulmon Dis. 2022 Jul 12;17:1565-1575. doi: 10.2147/COPD.S366126. eCollection 2022.
Early-life risk factors for reversible and irreversible airflow limitation in young adults: findings from the BAMSE birth cohort.
Wang G, Kull I, Bergström A, Hallberg J, Bergström PU, Guerra S, Pershagen G, Gruzieva O, van Hage M, Georgelis A, Janson C, Lindén A, Melén E.
Thorax. 2021 May;76(5):503-507. doi: 10.1136/thoraxjnl-2020-215884. Epub 2020 Nov 12.
Animal models of emphysema.
Liang GB, He ZH.
Chin Med J (Engl). 2019 Oct 20;132(20):2465-2475. doi: 10.1097/CM9.0000000000000469.
Asthma-COPD Overlap: What Are the Important Questions?
Leung C, Sin DD.
Chest. 2022 Feb;161(2):330-344. doi: 10.1016/j.chest.2021.09.036. Epub 2021 Oct 6.
Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease: A Review.
Riley CM, Sciurba FC.
JAMA. 2019 Feb 26;321(8):786-797. doi: 10.1001/jama.2019.0131.
Influencing Factors and Exercise Intervention of Cognitive Impairment in Elderly Patients with Chronic Obstructive Pulmonary Disease.
Wang T, Mao L, Wang J, Li P, Liu X, Wu W.
Clin Interv Aging. 2020 Apr 21;15:557-566. doi: 10.2147/CIA.S245147. eCollection 2020.
Irritant-Induced Asthma.
Lemiere C, Lavoie G, Doyen V, Vandenplas O.
J Allergy Clin Immunol Pract. 2022 Nov;10(11):2799-2806. doi: 10.1016/j.jaip.2022.06.045. Epub 2022 Jul 9.
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ.
N Engl J Med. 2004 Mar 4;350(10):1005-12. doi: 10.1056/NEJMoa021322.
Airflow limitation--reversible or irreversible.
[No authors listed]
Lancet. 1988 Jan 2-9;1(8575-6):26-7.
